Markets

Cerner's HealtheIntent Selected by Geisinger Health System

Cerner CorporationCERN recently announced that its HealtheIntent platform has been selected by Geisinger Health System. The integration of HealtheIntent with Geisinger's present system will facilitate advanced clinical outcomes through superior analysis of patient health and a wider access to a large data base. HealtheIntent will form an essential part of Geisinger's system-wide data management platform Unified Data Architecture (UDA).

HealtheIntent is a population health management platform that retrieves data from various sources, including Electronic Health Records (EHR) and Health Information Technology (HIT) systems, and helps organizations understand patients better and also provide appropriate treatment. It is a cloud-based platform that enables real-time access to and processing of data to provide improved and accurate health care.

Digitization of healthcare information through EHRs is a vital step for the medical industry. However, the assimilation of data from EHR platforms and other external sources needs to be done for a more personalized care and treatment of patients. HealtheIntent intends to provide such a service to Geisinger and other such organizations who have adopted the platform.

In fact, HealtheIntent has been gaining contracts for quite some time now. Most recently, HealtheIntent, along with Cerner Millennium EHR, was selected by McLaren Health Care for the implementation of EHR and population health management across their facilities in Michigan. Moreover, both these platforms were selected by Western Connecticut Health Network in September and by Baptist Health South Florida in August.

HealtheIntent is one of the major solutions that Cerner provides and its rising popularity will certainly boost revenues for the company in the future.

Zacks Rank & Key Picks

Cerner currently carries a Zacks Rank #3 (Hold).

Better-ranked stocks in the medical sector include Streamline Health Solutions STRM , Masimo Corporation MASI and Cesca Therapeutics KOOL . Each of these stocks sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CERNER CORP (CERN): Free Stock Analysis Report

MASIMO CORP (MASI): Free Stock Analysis Report

STREAMLINE HLTH (STRM): Free Stock Analysis Report

CESCA THERAP (KOOL): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

THMOMASISTRM

Other Topics

Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More